Ochre Bio
Ochre Bio is a biotech company based in Oxford, England, specializing in the development of RNA medicines for chronic liver diseases.
Company Overview
Ochre Bio operates in the Healthcare industry with a focus on Therapeutics. The company is located in Oxford, England, United Kingdom, and was part of the Y Combinator W20 batch. Ochre Bio employs a team of 50 people and is currently in its growth stage.
Geographical Presence and Work Environment
Ochre Bio is based in Oxford, England, United Kingdom, and has a regional focus on the United Kingdom and Europe. The company also offers remote and partly remote working options, catering to a diverse workforce.
Industry and Sub-industry Focus
Ochre Bio operates in the Healthcare industry, specifically within the Therapeutics sub-industry. The company's work is centered around developing RNA medicines aimed at treating chronic liver diseases. Tags associated with Ochre Bio include Biotech and Genomics.
Y Combinator Affiliation
Ochre Bio was part of the Y Combinator W20 batch. This affiliation has supported the company during its early stages and continues to contribute to its growth and development in the Healthcare sector.